Top compounds associated with response to SIRT6


Feature Type Standardized
Nominal ANOVA
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.062 0.1
mRNA Imatinib CTRPv2 pan-cancer AAC -0.063 0.1
mRNA ML203 CTRPv2 pan-cancer AAC -0.066 0.1
mRNA BRD-K29086754 CTRPv2 pan-cancer AAC -0.13 0.1
mRNA ZM-447439 GDSC1000 pan-cancer AAC 0.064 0.1
mRNA importazole CTRPv2 pan-cancer AAC -0.066 0.1
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.1
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.1
mRNA DMOG GDSC1000 pan-cancer AAC -0.056 0.1
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.1
Download CSV